Applications of Functional DNA Materials in Immunomodulatory Therapy
Source abstract
Abstract
In recent years, nanoscale or microscale functional materials derived from DNA have shown great potential for immunotherapy as superior delivery carriers. DNA nanostructures with excellent programmability and addressability enable the precise assembly of molecules or nanoparticles. DNA hydrogels have predictable structures and adjustable mechanical strength, thus being advantageous in controllable release of cargos. In addition, utilizing systematic evolution of ligands by exponential enrichment technology, a variety of DNA aptamers have been screened for specific recognition of ions, molecules, and even cells. Moreover, a wide variety of chemical modifications can further enrich the function of DNA. The unique advantages of functional DNA materials make them extremely attractive in immunomodulation. Recently, functional DNA materials-based immunotherapy has shown great potential in fighting against many diseases like cancer, viral infection, and inflammation. Therefore, in this review, we focus on discussing the progress of the applications of functional DNA materials in immunotherapy; before that, we also summarize the characteristics of the functional DNA materials descried above. Finally, we discuss the challenges and future opportunities of functional DNA materials in immunomodulatory therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Life Sciences, Shanghai University, Shanghai 200444, China
School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules and National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai 200240, China
Department of Clinical Laboratory Medicine, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200072, China
Funding
National Natural Science Foundation of China
References (100+)
Show source-provided references
1. 10.1021/acs.chemrev.0c0029410.1021/acs.chemrev.0c00294 ↗
2. 10.1016/0022-5193(82)90002-910.1016/0022-5193(82)90002-9 ↗
3. 10.1038/natrevmats.2017.6810.1038/natrevmats.2017.68 ↗
4. 10.1021/ja505101a10.1021/ja505101a ↗
5. 10.1021/acs.chemrev.7b0066310.1021/acs.chemrev.7b00663 ↗
6. 10.1038/350631a010.1038/350631a0 ↗
7. 10.1021/bi00064a00310.1021/bi00064a003 ↗
8. 10.1038/1643710.1038/16437 ↗
9. 10.1038/nature0827410.1038/nature08274 ↗
10. 10.1038/nature0458610.1038/nature04586 ↗
11. 10.1126/science.113249310.1126/science.1132493 ↗
12. 10.1038/nature0140610.1038/nature01406 ↗
13. 10.1126/science.113137210.1126/science.1131372 ↗
14. 10.1038/nature0801610.1038/nature08016 ↗
15. 10.1126/science.aaa537210.1126/science.aaa5372 ↗
16. 10.1038/nature0902610.1038/nature09026 ↗
17. 10.1126/science.122726810.1126/science.1227268 ↗
18. 10.1038/ncomms910210.1038/ncomms9102 ↗
19. 10.1002/anie.20150631210.1002/anie.201506312 ↗
20. 10.1038/415062a10.1038/415062a ↗
21. 10.1038/nnano.2010.510.1038/nnano.2010.5 ↗
22. 10.1038/ncomms1008910.1038/ncomms10089 ↗
23. 10.1038/nnano.2015.24610.1038/nnano.2015.246 ↗
24. 10.1002/anie.20150977210.1002/anie.201509772 ↗
25. 10.1021/nl301877k10.1021/nl301877k ↗
26. 10.1073/pnas.080072310510.1073/pnas.0800723105 ↗
27. 10.1016/0966-7822(96)00001-910.1016/0966-7822(96)00001-9 ↗
28. 10.1038/nmat174110.1038/nmat1741 ↗
29. 10.1002/adma.20100334310.1002/adma.201003343 ↗
30. 10.1039/C8BM01246F10.1039/C8BM01246F ↗
31. 10.1038/nnano.2012.21110.1038/nnano.2012.211 ↗
32. 10.1016/j.addr.2020.07.01810.1016/j.addr.2020.07.018 ↗
33. 10.1039/C5CS00586H10.1039/C5CS00586H ↗
34. 10.1038/346818a010.1038/346818a0 ↗
35. 10.1126/science.220012110.1126/science.2200121 ↗
36. 10.1038/355850a010.1038/355850a0 ↗
37. 10.1002/cmdc.20140231210.1002/cmdc.201402312 ↗
38. 10.1016/j.ccr.2019.21308010.1016/j.ccr.2019.213080 ↗
39. 10.3390/cancers1002004710.3390/cancers10020047 ↗
40. 10.1021/acsami.0c1956210.1021/acsami.0c19562 ↗
41. 10.1016/j.xinn.2022.10021710.1016/j.xinn.2022.100217 ↗
42. 10.1021/acs.chemrev.8b0057010.1021/acs.chemrev.8b00570 ↗
43. 10.1016/j.ctrv.2017.01.00810.1016/j.ctrv.2017.01.008 ↗
44. 10.1002/mabi.20210008310.1002/mabi.202100083 ↗
45. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
46. 10.1038/nrc206710.1038/nrc2067 ↗
47. 10.1016/j.cell.2011.11.01610.1016/j.cell.2011.11.016 ↗
48. 10.1002/smll.20190017210.1002/smll.201900172 ↗
49. 10.1016/S0092-8674(02)00625-610.1016/S0092-8674(02)00625-6 ↗
50. 10.1038/nrc325810.1038/nrc3258 ↗
51. 10.1038/cr.2016.15710.1038/cr.2016.157 ↗
52. 10.1126/science.aaa497110.1126/science.aaa4971 ↗
53. 10.1021/acs.accounts.9b0014810.1021/acs.accounts.9b00148 ↗
54. 10.1002/adma.20130087510.1002/adma.201300875 ↗
55. 10.1016/j.jconrel.2013.05.02210.1016/j.jconrel.2013.05.022 ↗
56. 10.1016/j.ijpharm.2017.09.03210.1016/j.ijpharm.2017.09.032 ↗
57. 10.1002/advs.20210032810.1002/advs.202100328 ↗
58. 10.1002/smll.20190050410.1002/smll.201900504 ↗
59. 10.1002/smll.20160288110.1002/smll.201602881 ↗
60. 10.1021/ja512293f10.1021/ja512293f ↗
61. 10.1038/s41563-020-0793-610.1038/s41563-020-0793-6 ↗
62. 10.1038/s41565-020-00813-z10.1038/s41565-020-00813-z ↗
63. 10.1002/anbr.20200004910.1002/anbr.202000049 ↗
64. 10.3389/fmicb.2019.0146210.3389/fmicb.2019.01462 ↗
65. 10.1038/s41563-021-01020-410.1038/s41563-021-01020-4 ↗
66. 10.1021/acsami.0c0087410.1021/acsami.0c00874 ↗
67. 10.1021/acsami.7b1792810.1021/acsami.7b17928 ↗
68. 10.1021/ja209351u10.1021/ja209351u ↗
69. 10.1021/ja960162o10.1021/ja960162o ↗
70. 10.1038/2899810.1038/28998 ↗
71. 10.1073/pnas.080384110510.1073/pnas.0803841105 ↗
72. 10.1039/b907800b10.1039/b907800b ↗
73. 10.1093/nar/gkp43610.1093/nar/gkp436 ↗
74. 10.1021/nl203503s10.1021/nl203503s ↗
75. 10.1038/nature0797110.1038/nature07971 ↗
76. 10.1039/b402293a10.1039/b402293a ↗
77. 10.1016/j.aca.2019.06.03410.1016/j.aca.2019.06.034 ↗
78. 10.1002/anie.20090451310.1002/anie.200904513 ↗
79. 10.1002/anie.20130275910.1002/anie.201302759 ↗
80. 10.1038/s41565-018-0113-310.1038/s41565-018-0113-3 ↗
81. 10.1073/pnas.071029510510.1073/pnas.0710295105 ↗
82. 10.1016/j.cell.2012.07.02110.1016/j.cell.2012.07.021 ↗
83. Qi H. · 2014 · 30 · 141
84. 10.1016/j.ijpharm.2016.11.04810.1016/j.ijpharm.2016.11.048 ↗
85. 10.1039/C4CC07144A10.1039/C4CC07144A ↗
86. 10.1021/acsami.9b0865210.1021/acsami.9b08652 ↗
87. 10.1039/C1CC11028D10.1039/C1CC11028D ↗
88. 10.1021/bm401155a10.1021/bm401155a ↗
89. 10.1039/C5NR00858A10.1039/C5NR00858A ↗
90. 10.1002/cbic.20150068610.1002/cbic.201500686 ↗
91. 10.1021/acsami.1c1444510.1021/acsami.1c14445 ↗
92. 10.1002/anie.20220252010.1002/anie.202202520 ↗
93. 10.1021/jacs.6b1045810.1021/jacs.6b10458 ↗
94. 10.1038/nrd195510.1038/nrd1955 ↗
95. 10.1021/ac052015r10.1021/ac052015r ↗
96. 10.1021/acs.nanolett.1c0258210.1021/acs.nanolett.1c02582 ↗
97. 10.1038/mtna.2015.1110.1038/mtna.2015.11 ↗
98. 10.1126/science.121408110.1126/science.1214081 ↗
99. 10.1002/anie.20180901010.1002/anie.201809010 ↗
100. 10.3390/cancers1001000910.3390/cancers10010009 ↗